A detailed history of Amalgamated Bank transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Amalgamated Bank holds 207,486 shares of ROIV stock, worth $2.49 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
207,486
Previous 196,128 5.79%
Holding current value
$2.49 Million
Previous $2.07 Million 15.48%
% of portfolio
0.02%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$10.17 - $12.5 $115,510 - $141,975
11,358 Added 5.79%
207,486 $2.39 Million
Q2 2024

Aug 12, 2024

BUY
$10.36 - $11.74 $45,521 - $51,585
4,394 Added 2.29%
196,128 $2.07 Million
Q1 2024

Apr 23, 2024

BUY
$9.87 - $11.8 $1.2 Million - $1.43 Million
121,426 Added 172.71%
191,734 $2.02 Million
Q4 2023

Feb 06, 2024

SELL
$8.38 - $11.58 $2,899 - $4,006
-346 Reduced 0.49%
70,308 $790,000
Q3 2023

Nov 08, 2023

BUY
$9.76 - $13.19 $180,979 - $244,582
18,543 Added 35.58%
70,654 $825,000
Q2 2023

Aug 11, 2023

BUY
$7.09 - $10.08 $369,466 - $525,278
52,111 New
52,111 $525,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.45B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.